Keebeck Alpha, LP Accelerate Diagnostics, Inc Transaction History

Keebeck Alpha, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$1.4 - $5.15 $30,423 - $111,914	-21,731 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$4.27 - $6.97 $44,190 - $72,132	10,349 Added 90.92%	21,731 $113,000
Q3 2021 Nov 09, 2021	BUY	$5.31 - $8.25 $60,438 - $93,901	11,382 New	11,382 $66,000
Q2 2020 Aug 06, 2020	SELL	$7.49 - $15.16 $144,429 - $292,330	-19,283 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$4.62 - $18.74 $89,087 - $361,363	19,283 New	19,283 $161,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.